The company said it will use the funds to commercialize its proteomic PromarkerD kidney disease test and launch an analytical testing service business.
Metabolon will work with Johns Hopkins University and Tufts Medical Center to develop and clinically validate the new blood-based diagnostic.
In PLOS this week: NEK8 mutations in a ciliopathy disorder, characterization of the tea species Camellia sinensis, and more.
Researchers from the University of Michigan are beginning to use Drop-Seq to characterize human kidney cells.
With data from the CanPREDDICT study, the partners will develop a test to predict the rate of disease progression in patients with chronic kidney disease.
In PLOS this week: gene expression differences in plants susceptible to or resistant to Plum pox virus, novel human pegivirus, and more.
Using transcripts expressed in kidney tissue as a guide, researchers identified a protein marker of chronic kidney disease progression and kidney function in urine.
Clinicians in the hospital will use IBM's Watson to identify possible options for diagnosing and treating rare pediatric diseases starting with kidney disease.
Researchers have sequenced and analyzed more than 50 feral and domestic cats in search of genetic variants involved in specific physical features and forms of disease.
SGI will use unique DNA design, DNA synthesis, genome editing, and genome modification tools to develop engineered primary pig cells with modified genomes.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.